Valuation: Balchem Corporation

Market Cap 542.83Cr 476.61Cr 438.7Cr 408.79Cr 770.95Cr 52TCr 786.62Cr 5.28TCr 2.04TCr 25TCr 2.04TCr 1.99TCr 88TCr P/E 2026 *
32.3x
P/E 2027 * 30.7x
Enterprise Value 546.03Cr 479.42Cr 441.28Cr 411.2Cr 775.5Cr 52TCr 791.25Cr 5.31TCr 2.06TCr 25TCr 2.05TCr 2.01TCr 89TCr EV / Sales 2026 *
4.94x
EV / Sales 2027 * 4.63x
Free-Float
99.53%
Yield 2026 *
0.67%
Yield 2027 * 0.75%
1 day-0.04%
1 week-0.23%
Current month-0.04%
1 month+8.06%
3 months-1.74%
6 months+9.65%
Current year+10.13%
1 week 165.46
Extreme 165.465
174.09
1 month 155.87
Extreme 155.87
174.09
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 59.07
Extreme 59.07
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap.
01/04Other

Controller/Auditor

8,646 0.0270%
11/02Free

Director

870 0.0027%
11/02Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%-0.23%+4.33%+25.50% 542.83Cr
-0.09%+0.75%+2.11%+49.20% 7.84TCr
+0.64%+5.00%-10.39%+16.09% 3.91TCr
+1.20%+4.78%-21.66%-34.00% 3.31TCr
-0.49%+4.40%+10.31%+21.74% 2.56TCr
-0.87%-2.14%+14.69%+1.48% 2.01TCr
+0.24%-1.80%+110.79%-3.06% 2.11TCr
+2.09%+0.47%-35.40%-35.51% 1.83TCr
+0.78%-7.95%+116.34%-40.64% 1.59TCr
-5.35%+9.86%+249.72%+305.58% 1.48TCr
Average -0.18%-0.90%+44.09%+30.64% 2.72TCr
Weighted average by Cap. +0.20%+0.72%+25.26%+26.64%

Financials

2026 *2027 *
Net sales 110.64Cr 97Cr 89Cr 83Cr 157.13Cr 11TCr 160.33Cr 1.08TCr 416.67Cr 5.16TCr 415.41Cr 406.43Cr 18TCr 116.5Cr 102.28Cr 94Cr 88Cr 165.45Cr 11TCr 168.81Cr 1.13TCr 438.73Cr 5.44TCr 437.41Cr 427.95Cr 19TCr
Net income 17Cr 15Cr 14Cr 13Cr 24Cr 1.61TCr 25Cr 164.89Cr 64Cr 791.64Cr 64Cr 62Cr 2.76TCr 18Cr 16Cr 14Cr 13Cr 25Cr 1.7TCr 26Cr 173.59Cr 67Cr 833.42Cr 67Cr 66Cr 2.9TCr
Net Debt 3.2Cr 2.81Cr 2.58Cr 2.41Cr 4.54Cr 304.02Cr 4.63Cr 31Cr 12Cr 149.23Cr 12Cr 12Cr 519.35Cr -4.03Cr -3.53Cr -3.25Cr -3.03Cr -5.72Cr -382.78Cr -5.83Cr -39Cr -15Cr -187.89Cr -15Cr -15Cr -653.9Cr
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,368
Date Price Change Volume
02/26/02 $168.89 -0.04% 2,17,522
30/26/30 $168.95 -0.15% 4,91,374
29/26/29 $169.21 -1.17% 2,63,560
26/26/26 $171.22 +1.18% 7,61,793
25/26/25 $169.23 -0.03% 1,86,984
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
168.95USD
Average target price
200.75USD
Spread / Average Target
+18.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock